<?xml version="1.0" encoding="UTF-8"?>
<p id="par0080">In light of this evidence, people with cancer may paradoxically be protected from excessive immune system stimulation of CoV infections. 
 <xref rid="tbl0010" ref-type="table">Table 2</xref> outlines the characteristics of immune mechanisms involved in the following conditions: CoV infection, cancer, chemotherapy and immunotherapy. Cancer itself determines an immunocompromised status in the host, which is modulated by immunosuppressive treatments, as cytotoxic chemotherapy (
 <xref rid="bib0035" ref-type="bibr">Emens and Middleton, 2015</xref>). This might partially explain why cancer did not seem to represent a significant risk factor during the two last SARS-CoV and MERS-CoV epidemics. Limited data on COVID-19 case series are available to date, suggesting that cancer diagnosis is under-represented in patients with COVID-19, compared with other comorbidities (e.g. cardiovascular disease, diabetes, obesity).
</p>
